A Historic Perspective and Future Directions
RALEIGH, N.C., Feb. 12 /PRNewswire/ -- PRA International, a leading Clinical Research Organization, will host a prominent panel of infectious disease experts in Boston at 9:00 a.m. on February 25. Discussions will include case scenarios on cutting edge research in the field of HCV which are applicable to other fields of infectious disease research.
The agenda includes presentations by Dr. Carl Kraus - PRA's Vice President of Infectious Diseases, Barry Werth, author of "The Billion Dollar Molecule: One Company's Quest for the Perfect Drug", Dr. John McHutchison - Professor of Medicine in Duke University's Department of Hepatology, and Dr. Nezam Afdhal, Professor of Medicine at
More than one-third of PRA's project management and clinical operations employees are experienced in infectious diseases clinical research. PRA's Infectious Diseases Research Center supports the CRO's infectious disease project teams, cross-functional groups that provide oversight and risk mitigation strategies for the inherently complex drug development process.
Further information about this free event is available on PRA's website at http://www.praintl.com/News%20%20Events/Events or by contacting Gayle Yotch at email@example.com or by phone at 781-942-9573.
About PRA International
PRA International is a global Clinical Research Organization providing services through all phases of clinical development. Although PRA specializes in Infectious Diseases, Oncology, CNS, Respiratory/Allergy, and Cardiovascular, it performs studies in all therapeutic areas. PRA has supported over 2,100 clinical trials through its 32 global offices. PRA's therapeutic expertise, global reach and project experience, combined with extensive local knowledge, enable its project teams to deliver consistent and on time performance for its clients.
|SOURCE PRA International|
Copyright©2009 PR Newswire.
All rights reserved